Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 21 results.
User Information
Export Records
  1. 1.   Are We Making PROGRESS in Preventing Graft-versus-Host Disease and Improving Clinical Outcomes? Impact of BMT CTN 1301 Study Results on Clinical Practice
  2. Hamilton, Betty K; Cutler, Corey; Divine, Clint; Juckett, Mark; LeMaistre, Charles; Stewart, Susan; Wilder, Jennifer; Horowitz, Mary; Khera, Nandita; Burns, Linda J
  3. Transplantation and Cellular Therapy. 2022, May 09;
  1. 2.   Donor source and post-transplantation cyclophosphamide influence outcome in allogeneic stem cell transplantation for GATA2 deficiency
  2. Nichols-Vinueza, Diana X; Parta,Mark; Shah, Nirali N; Cuellar-Rodriguez, Jennifer M; Bauer, Thomas R; West, Robert R; Hsu, Amy P; Calvo, Katherine R; Steinberg, Seth M; Notarangelo, Luigi D; Holland, Steven M; Hickstein, Dennis D
  3. British journal of haematology. 2021, Sep 27;
  1. 3.   Combined haploidentical and cord blood transplantation for refractory severe aplastic anaemia and hypoplastic myelodysplastic syndrome
  2. Childs, Richard W; Tian, Xin; Vo, Phuong; Purev, Enkhtsetseg; Kotecha, Ritesh R; Carlsten, Mattias; Clara, Joseph; Flegel, Willy A; Adams, Sharon D; Khuu, Hanh M; Stroncek, David F; Cook, Lisa; Worthy, Tat'yana; Geller, Nancy L; Wells, Brian; Wilder,Jennifer; Reger, Robert; Aue, Georg
  3. British Journal of Haematology. 2021, May 15; 193(5): 951-960.
  1. 4.   Transplantation of CCR5 Delta 32 Homozygous Umbilical Cord Blood in a Child With Acute Lymphoblastic Leukemia and Perinatally Acquired HIV Infection
  2. Rothenberger, Meghan; Wagner, John E; Haase, Ashley; Richman, Douglas; Grzywacz, Bartosz; Strain, Matthew; Lada, Steven; Estes, Jake; Fletcher, Courtney V; Podany, Anthony T; Anderson, Jodi; Schmidt, Thomas; Wietgrefe, Steve; Schacker, Timothy; Verneris, Michael R
  3. Open forum infectious diseases. 2018, May; 5(5): ofy090.
  1. 5.   Characterization and comparison of galactomannan enzyme immunoassay and quantitative real-time PCR assay for detection of Aspergillus fumigatus in bronchoalveolar lavage fluid from experimental invasive pulmonary aspergillosis
  2. Francesconi, A.; Kasai, M.; Petraitiene, R.; Petraitis, V.; Kelaher, A. M.; Schaufele, R.; Hope, W. W.; Shea, Y. R.; Bacher, J.; Walsh, T. J.
  3. Journal of Clinical Microbiology. 2006, Jul; 44(7): 2475-2480.
  1. 6.   Peyer patches are not required for acute graft-versus-host disease after myeloablative conditioning and murine allogeneic bone marrow transplantation
  2. Welniak, L. A.; Kuprash, D. V.; Tumanov, A. V.; Panoskaltsis-Mortari, A.; Blazar, B. R.; Sun, K.; Nedospasov, S. A.; Murphy, W. J.
  3. Blood. 2006, JAN 1; 107(1): 410-412.
  1. 7.   HLA class I diversity among rural rainforest inhabitants in Cameroon: identification of A*2612-B*4407 haplotype
  2. Torimiro, J. N.; Carr, J. K.; Wolfe, N. D.; Karacki, P.; Martin, M. P.; Gao, X.; Tamoufe, U.; Thomas, A.; Ngole, E. M.; Birx, D. L.; McCutchan, F. E.; Burke, D. S.; Carrington, M.
  3. Tissue Antigens. 2006, JAN; 67(1): 30-37.
  1. 8.   Differential effects of proteasome inhibition by bortezomib on murine acute graft-versus-host disease (GVHD): delayed administration of bortezomib results in increased GVHD-dependent gastrointestinal toxicity
  2. Sun, K.; Wilkins, D. E. C.; Anver, M. R.; Sayers, T. J.; Panoskaltsis-Mortari, A.; Blazar, B. R.; Weiniak, L. A.; Murphy, W. J.
  3. Blood. 2005, NOV 1; 106(9): 3293-3299.
  1. 9.   Limiting dilution analysis of interleukin-2 producing helper T-cell frequencies as a tool in allogeneic hematopoietic cell transplantation
  2. Petersen, S. L.; Sidorov, I. A.; Russell, C. A.; Dickmeiss, E.; Vindelov, L. L.
  3. Transplantation. 2005, SEP 15; 80(5): 573-581.
  1. 10.   Human tumor antigen MUC1 is chemotactic for immature dendritic cells and elicits maturation but does not promote Th1 type immunity
  2. Carlos, C. A.; Dong, H. F.; Howard, O. M. Z.; Oppenheim, J. J.; Hanisch, F. G.; Finn, O. J.
  3. Journal of Immunology. 2005, AUG 1; 175(3): 1628-1635.
  1. 11.   Rapid conversion of effector mechanisms from NK to T cells during virus-induced lysis of allogeneic implants in vivo
  2. Brehm, M. A.; Daniels, K. A.; Ortaldo, J. R.; Welsh, R. M.
  3. Journal of Immunology. 2005, JUN 1; 174(11): 6663-6671.
  1. 12.   Host conditioning is a primary determinant in modulating the effect of IL-7 on murine graft-versus-host disease
  2. Gendelman, M.; Hecht, T.; Logan, B.; Vodanovic-Jankovic, S.; Komorowski, R.; Drobyski, W. R.
  3. Journal of Immunology. 2004 172(5): 3328-3336.
  1. 13.   An absence of CCR5 on donor cells results in acceleration of acute graft-vs-host disease
  2. Welniak, L. A.; Wang, Z.; Sun, K.; Kuziel, W.; Anver, M. R.; Blazar, B. R.; Murphy, W. J.
  3. Experimental Hematology. 2004 32(3): 318-324.
  1. 14.   Inhibition of acute graft-versus-host disease with retention of graft-versus-tumor effects by the proteasome inhibitor bortezomib
  2. Sun, K.; Welniak, L. A.; Panoskaltsis-Mortari, A.; O'Shaughnessy, M. J.; Liu, H. Y.; Barao, I.; Riordan, W.; Sitcheran, R.; Wysocki, C.; Serody, J. S.; Blazar, B. R.; Sayers, T. J.; Murphy, W. J.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2004 101(21): 8120-8125.
  1. 15.   Dissociation of NKT stimulation, cytokine induction, and NK activation in vivo by the use of distinct TCR-binding ceramides
  2. Ortaldo, J. R.; Young, H. A.; Winkler-Pickett, R. T.; Bere, E. W.; Murphy, W. J.; Wiltrout, R. H.
  3. Journal of Immunology. 2004 172(2): 943-953.
  1. 16.   The absence of Peyer's patches or host TNF-alpha does not affect GVHD progression in an allogeneic BMT model using extensive conditioning regimens
  2. Welniak, L. A.; Kuprash, D. V.; Tumanov, A. V.; Sun, K.; Stull, S. W.; Anver, M. R.; Nedospasov, S. A.; Murphy, W. J.
  3. Biology of Blood and Marrow Transplantation. 2004 10(2, Suppl. 1): 52-52.
  1. 17.   Direct relationship between suppression of virus-specific immunity and emergence of cytomegalovirus disease in simian AIDS
  2. Kaur, A.; Kassis, N.; Hale, C. L.; Simon, M.; Elliott, M.; Gomez-Yafal, A.; Lifson, J. D.; Desrosiers, R. C.; Wang, F.; Barry, P.; Mach, M.; Johnson, R. P.
  3. Journal of Virology. 2003 77(10): 5749-5758.
  1. 18.   PS-341 administration inhibits acute graft-versus-host disease and preserves graft-versus-tumor after allogeneic BMT in advanced tumor-bearing mice
  2. Sun, K.; Welniak, L. A.; Wilkins, D.; Panoskaltsis-Mortari, A.; Blazar, B. R.; Sayers, T. J.; Murphy, W. J.
  3. Blood. 2003 102(11, Part 1): 192A-192A.
  1. 19.   Host T cells resist graft-versus-host disease mediated by donor leukocyte infusions
  2. Blazar, B. R.; Lees, C. J.; Martin, P. J.; Noelle, R. J.; Kwon, B.; Murphy, W.; Taylor, P. A.
  3. Journal of Immunology. 2000 165(9): 4901-4909.
  1. 20.   Adoptive cellular immunotherapy: NK cells and bone marrow transplantation
  2. Koh, C. Y.; Welniak, L. A.; Murphy, W. J.
  3. Histology and Histopathology. 2000 15(4): 1201-1210.
  1. 21.   Decoupling blood telomere length from age in recipients of allogeneic hematopoietic cell transplant in the BMT-CTN 1202
  2. Lai, Tsung-Po; Verhulst, Simon; Dagnall,Casey; Hutchinson,Amy; Spellman, Stephen R; Howard, Alan; Katki, Hormuzd A; Levine, John E; Saber, Wael; Aviv, Abraham; Gadalla, Shahinaz M
  3. Frontiers in Immunology. 2022 13: 966301.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel